SCHEMBL7656444

SCHEMBL7656444

O=C(Nc1ccc2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1)Nc1ccc(Cl)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.49
MAPT P10636 7/20 0.49
MEN1 O00255 7/20 0.49
KDM4E B2RXH2 6/20 0.49
TP53 P04637 5/20 0.49
CYP3A4 P08684 5/20 0.49
CYP2C9 P11712 5/20 0.49
HSD17B10 Q99714 5/20 0.49
ALOX15 P16050 4/20 0.49
RECQL P46063 4/20 0.49
ALOX12 P18054 3/20 0.49
CDK2 P24941 3/20 0.49
MAPK1 P28482 3/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C19 P33261 2/20 0.49
ST6GAL1 P15907 1/20 0.49
CSNK2A2 P19784 3/20 0.47
CSNK2B P67870 3/20 0.47
CSNK2A1 P68400 3/20 0.47
MKNK2 Q9HBH9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666772 0.86 NPC1 (0.64) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL7663171 0.84 MEN1 (0.55) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL7658406 0.83 KDM4E (0.62) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL7658183 0.82 SNCA (0.61) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL7652753 0.82 MEN1 (0.55) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL7652737 0.81 MEN1 (0.68) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL7664270 0.79 MEN1 (0.55) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL7652860 0.79 MEN1 (0.60) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL7652030 0.78 MEN1 (0.51) KMT2AMAPTMEN1KDM4ETP53
SCHEMBL7659342 0.77 MEN1 (0.52) KMT2AMAPTMEN1KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500846-B1 2-(4-CHLOROPHENYL)-7-METHOXYCHROMEN-4-ONE, AS CYCLIN-DEPENDENT KINASE INHIBITORS, USED AS ANTICARCINOGENIC AGENTS OR FOR PROPHYLAXIS OF NEURODEGENERATIVE DISEASE LG CHEMICAL, LTD. (KR) 2002-12-31 US disclosed
EP-1109800-A1 NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE LG CHEMICAL LIMITED (KR) 2001-06-27 EP disclosed
WO-2000012496-A1 NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE LG CHEMICAL LTD. (KR) 2000-03-09 WO disclosed